| US2688022A (en)* | 1953-04-13 | 1954-08-31 | Searle & Co | 1-aminoalkyl-3-carbolines |
| US2767179A (en)* | 1954-02-12 | 1956-10-16 | Irwin Neisler And Company | Quaternary ammonium salts of carboline derivatives |
| US2800474A (en)* | 1956-03-26 | 1957-07-23 | Searle & Co | 9-(piperazinoalkyl) norharman derivatives |
| GB1268772A (en) | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME |
| US5344654A (en) | 1988-04-08 | 1994-09-06 | Stryker Corporation | Prosthetic devices having enhanced osteogenic properties |
| US5324819A (en) | 1988-04-08 | 1994-06-28 | Stryker Corporation | Osteogenic proteins |
| US5266683A (en) | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
| US5298852A (en) | 1988-12-22 | 1994-03-29 | Robert Bosch Gmbh | Arrangement for and method of controlling a three-phase-generator in a vehicle |
| US5656593A (en) | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
| AU674500B2 (en) | 1991-11-04 | 1997-01-02 | Genetics Institute, Llc | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| EP0548553A1 (en) | 1991-11-25 | 1993-06-30 | Takeda Chemical Industries, Ltd. | Optically active azole compounds, their production and use |
| IT1255522B (en) | 1992-09-24 | 1995-11-09 | Ubaldo Conte | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS |
| TW270114B (en) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| DE4435477A1 (en) | 1994-10-04 | 1996-04-11 | Bayer Ag | Cycloalkano-indole and -azaindole derivatives |
| DE4436190A1 (en) | 1994-10-10 | 1996-04-11 | Gerhard Prof Dr Bringmann | Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain |
| DE19613549A1 (en) | 1996-04-04 | 1997-10-09 | Bayer Ag | Process for the preparation of enantiomerically pure cycloalkano-indole and azaindole-carboxylic acids and their activated derivatives |
| US5939039A (en) | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
| DE69814352T3 (en) | 1997-02-07 | 2009-08-13 | Stryker Corp., Kalamazoo | MATRIXLESS OSTEOUS DEVICES AND IMPLANTS AND METHOD FOR THEIR USE |
| US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| WO2000002878A1 (en) | 1998-07-11 | 2000-01-20 | University Of Bristol | Compounds having activity at imidazoline receptors |
| US6025538A (en) | 1998-11-20 | 2000-02-15 | Musculoskeletal Transplant Foundation | Compound bone structure fabricated from allograft tissue |
| EP1165075A4 (en) | 1999-03-10 | 2002-04-10 | Merck & Co Inc | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| US20070060606A1 (en) | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
| EP1209158A1 (en) | 2000-11-18 | 2002-05-29 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines |
| EP1134221A1 (en) | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
| YU65502A (en) | 2000-03-15 | 2005-11-28 | Aventis Pharma Deutschland Gmbh. | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| US20030082233A1 (en) | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
| NZ528320A (en) | 2001-02-23 | 2005-07-29 | Wyeth Corp | Composition for inducing cartilaginous tissue formation and maintenance comprising a non-culture expanded CD105+ cells and a BMP |
| US6949251B2 (en) | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
| TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
| WO2003070288A2 (en) | 2001-10-12 | 2003-08-28 | Inframat Corporation | Coated implants and methods of coating implants |
| JP3646167B2 (en) | 2002-02-19 | 2005-05-11 | 独立行政法人産業技術総合研究所 | Composite biomaterials containing phosphophorin |
| US7176322B2 (en)* | 2002-05-23 | 2007-02-13 | Amgen Inc. | Calcium receptor modulating agents |
| US20050085554A1 (en) | 2003-06-26 | 2005-04-21 | Hamann Mark T. | Methods of treating disease through the administration of a manzamine analog or derivative |
| FI20031120A0 (en) | 2003-07-31 | 2003-07-31 | Bci Bioabsorbable Concepts Ltd | Multifunctional implant device |
| US7189263B2 (en) | 2004-02-03 | 2007-03-13 | Vita Special Purpose Corporation | Biocompatible bone graft material |
| US8071574B2 (en) | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
| JP4909900B2 (en) | 2005-09-08 | 2012-04-04 | 出光興産株式会社 | Organic electroluminescence device |
| CA2634131C (en) | 2005-12-21 | 2014-02-11 | Wyeth | Protein formulations with reduced viscosity and uses thereof |
| WO2007091707A1 (en) | 2006-02-10 | 2007-08-16 | Erina Co., Inc. | Pharmaceutical composition for preventing and/or treating bone disease, functional food, health food, pharmaceutical preparation and tooth root-periodontal tissue formation promoting agent containing the composition |
| US7812018B2 (en)* | 2006-02-16 | 2010-10-12 | Millennium Pharmaceuticals, Inc. | Alpha carbolines and uses thereof |
| WO2009029625A1 (en)* | 2007-08-27 | 2009-03-05 | Kalypsys, Inc. | 4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors |
| CN101932325B (en)* | 2007-11-30 | 2014-05-28 | 新联基因公司 | Ido inhibitors |
| US8932557B2 (en) | 2008-02-14 | 2015-01-13 | Eli Lilly And Company | Imaging agents for detecting neurological dysfunction |
| NZ587929A (en)* | 2008-03-28 | 2012-10-26 | Altiris Therapeutics | Chemokine receptor modulators |
| EP2151441A1 (en) | 2008-08-06 | 2010-02-10 | Julius-Maximilians-Universität Würzburg | Beta-carbolin-derivates as substrates for an enzyme |
| US20100063085A1 (en) | 2008-09-11 | 2010-03-11 | University Court Of The University Of Dundee | Method of treating learning impairment in down's syndrome subjects |
| WO2010036567A2 (en)* | 2008-09-25 | 2010-04-01 | Osteogenex Inc. | Harmine compounds for promoting bone growth |
| WO2010080756A2 (en) | 2009-01-06 | 2010-07-15 | Osteogenex, Inc. | Harmine derivatives for reducing body weight |
| WO2010123583A2 (en) | 2009-04-24 | 2010-10-28 | University Of Tennessee Research Foundation | 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof |
| US8927570B2 (en) | 2009-04-24 | 2015-01-06 | John K. Buolamwini | 1-naphthyl-or 1-dihydroacenaphthenyl-pyrido[B]indoles and uses thereof in treating cancers |
| CA2785233C (en)* | 2009-12-28 | 2018-10-09 | Audiocure Pharma Gmbh | .beta.-carbolines for treatment of hearing damages and vertigo |
| US20130231360A1 (en) | 2010-04-22 | 2013-09-05 | The Brigham And Women S Hospital, Inc. | Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases |
| EP2585463A1 (en) | 2010-06-25 | 2013-05-01 | Facultés Universitaires Notre-Dame de la Paix | Beta carboline derivatives useful in the treatment of proliferative disorders |
| WO2012024433A2 (en) | 2010-08-17 | 2012-02-23 | Translational Genomics Research Institute | Compounds that inhibit tau phosphorylation |
| CN102796124B (en) | 2011-05-26 | 2017-06-06 | 新疆华世丹药物研究有限责任公司 | Double β carbolines alkaloid compounds, its preparation method and its pharmaceutical composition and purposes |
| US20130315965A1 (en) | 2012-05-15 | 2013-11-28 | OssiFi, Inc. | Harmine derivatives for promoting bone growth |
| PL2968284T3 (en)* | 2013-03-14 | 2021-09-27 | Osteoqc Inc. | Alkyl-amine harmine derivatives for promoting bone growth |
| WO2018024643A1 (en) | 2016-08-02 | 2018-02-08 | Ucb Biopharma Sprl | 9h-pyrrolo-dipyridine derivatives |